Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.06%
#3 BankrCoin BankrCoin +20.27%
#4 MarsCoin MarsCoin +19.67%
#5 Ankr Network Ankr Network +18.93%
#6 Hive Hive +18.83%
#7 StonkBroker StonkBroker +14.43%
#8 Status Status +12.01%
#9 Prom Prom +11.13%
#10 Provenance Blockchain Provenance Blockchain +8.75%
Coin of the day
Palladium Network Palladium Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc.

ODTC
Rangering i aksjer #18159
Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and... Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and headquartered in New York, New York, is dedicated to creating treatments for cancer. Its primary therapeutic in development is tesetaxel, an orally administered chemotherapy drug. This agent is currently undergoing a Phase III clinical study for its application in patients suffering from metastatic breast cancer.
Aksjekurs
$150,000
Sist synkronisert: 2025-02-11
Markedsverdi
$210.38M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Odonate Therapeutics, Inc. (ODTC)

Kategori

Healthcare
P/S-forhold for Odonate Therapeutics, Inc. (ODTC)
P/S-forhold per 2026 TTM: 0
Ifølge Odonate Therapeutics, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Odonate Therapeutics, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH